Previous 10 | Next 10 |
SOPHiA GENETICS SA (SOPH) Q1 2022 Earnings Conference Call May 10, 2022 08:30 AM ET Company Participants Jennifer Pottage - Head of IR Jurgi Camblong - Co-Founder, CEO and Director Ross Muken - Senior VP and CFO Conference Call Participants Dan Brennan - Cowen Tejas Savant - Morgan Stanley Ju...
Image source: The Motley Fool. Sophia Genetics SA (NASDAQ: SOPH) Q1 2022 Earnings Call May 10, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Sophia Genetics SA (SOPH) Q1 2022 Earnings Call Transcript
The following slide deck was published by SOPHiA GENETICS SA in conjunction with their 2022 Q1 earnings call. For further details see: SOPHiA GENETICS SA 2022 Q1 - Results - Earnings Call Presentation
SOPHiA Genetics press release (NASDAQ:SOPH): Q1 Non-GAAP EPS of -$0.34 misses by $0.04. Revenue of $10.86M (+20.9% Y/Y) misses by $0.09M. SOPHiA GENETICS’ (SOPH) expectation of 30% to 35% constant currency revenue growth for full-year 2022 remains unchanged. To reflect the impact of th...
BOSTON, United States and LAUSANNE, Switzerland, May 10, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today reported financial results for the first quarter ended March 31, 2022. Recent Highlights Revenue for the first quarter...
SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors Canada NewsWire BOSTON and LAUSANNE, Switzerland , May 5, 2022 /CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, today announced the ...
BOSTON and LAUSANNE, Switzerland, April 27, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced CFO, Ross Muken will attend the upcoming J.P. Morgan 50 th Annual Global Technology, Media, and Communications Conference in Bos...
SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform Canada NewsWire BOSTON and LAUSANNE, Switzerland , April 26, 2022 /CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine...
BOSTON and LAUSANNE, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal 2022 before U.S. markets open on Tuesday, May 10, 2022. SOPHiA...
Image source: The Motley Fool. Sophia Genetics SA (NASDAQ: SOPH) Q4 2021 Earnings Call Mar 15, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Sophia Genetics SA (SOPH) Q4 2021 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™ Canada NewsWire The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , July 2...
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24 , 2024 /PRN...
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS ® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24, 2024 /...